Study highlights link between sleep disturbances and behavioral issues in preschool children

Study reveals a significant association between sleep disturbances and emotional and behavioral difficulties (EBDs) in preschool children, emphasizing the import

Merck’s Keytruda receives approval greenlight from EU CHMP –

Keytruda is an anti-programmed death receptor-1 therapy that helps enhance the capability of the body’s immune system. Credit: Merck & Co. The European Medicines Agency’s

October 13, 2023

Henry Schein expects cyber incident costs to continue in 2024

By the numbers Q4 sales: $3 billion 12% decrease year over year Q4 net income: $18 million Compared to $47 million in Q4 2022 A

February 27, 2024

Cybin Launches Renewed ATM Equity Program Up To $35M

Psychedelics biotech Cybin Inc. CYBN announced it has renewed its previously established at-the-market (ATM) equity program allowing the company to gradually issue and sell up to $35 million in common shares

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.